Infinity Pharmaceutical (INFI) PT Slashed to $4 at Truist Securities, Continues to Sees Substantial Potential Upside but Cites Cash Overhang
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas lowered the price target on Infinity Pharmaceutical (NASDAQ: INFI) to $4.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
